Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 6


Protective effects of N-acetylcysteine in concanavalin A-induced hepatitis in mice.

Wang C, Xia Y, Zheng Y, Dai W, Wang F, Chen K, Li J, Li S, Zhu R, Yang J, Yin Q, Zhang H, Wang J, Lu J, Zhou Y, Guo C.

Mediators Inflamm. 2015;2015:189785. doi: 10.1155/2015/189785. Epub 2015 Mar 2.


Role of serotonergic system on modulation of depressogenic-like effects of silymarine.

Yaghmaei P, Oryan S, Mohammadi K, Solati J.

Iran J Pharm Res. 2012 Winter;11(1):331-7.


Complementary and alternative medicines for hepatic disease.

Seeff LB.

Gastroenterol Hepatol (N Y). 2008 Jan;4(1):33-5. No abstract available.


Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial.

Fried MW, Navarro VJ, Afdhal N, Belle SH, Wahed AS, Hawke RL, Doo E, Meyers CM, Reddy KR; Silymarin in NASH and C Hepatitis (SyNCH) Study Group.

JAMA. 2012 Jul 18;308(3):274-82. doi: 10.1001/jama.2012.8265.


Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial.

Freedman ND, Curto TM, Morishima C, Seeff LB, Goodman ZD, Wright EC, Sinha R, Everhart JE; HALT-C Trial Group.

Aliment Pharmacol Ther. 2011 Jan;33(1):127-37. doi: 10.1111/j.1365-2036.2010.04503.x. Epub 2010 Nov 2.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk